SEB Asset Management AB »

Ascendis Pharma A S shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.8M 39k 228.73

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Ascendis Pharma A S

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
FMR
Artisan Partners Limited Partnership
Franklin Resources
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
Perceptive Advisors
American Century Companies
Capital World Investors
Principal Financial Group
Ameriprise Financial

View all funds holding Ascendis Pharma A S